Experts Highlight How GLP-1s Have Revolutionized Management of T2D and Obesity
The number of Americans with type 2 diabetes and/or obesity is rising, and the entry of therapies such as glucagon-like peptide-1 (GLP-1) receptor agonists has been revolutionary.
Source: ajmc.com